Frazier Life Sciences Adds Industry Veteran and Serial Dealmaker, Adam Simpson, to Company Creation Team
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 19 2024
0mins
Source: Newsfilter
Adam Simpson's New Role: Adam Simpson has joined Frazier Life Sciences as a Venture Partner, bringing over 25 years of experience in building and leading life sciences companies that have achieved significant exits, including his recent role as CEO of Icosavax.
Frazier Life Sciences Overview: Frazier Life Sciences is a prominent investment firm focused on innovative biopharmaceuticals, managing over $3.9 billion in capital and having successfully supported numerous companies through IPOs and acquisitions since its inception.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
